• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters".

作者信息

Figarella-Branger Dominique, Dehais Caroline, Colin Carole, Ducray François

机构信息

APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.

Aix-Marseille Univ., CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.

出版信息

Neuro Oncol. 2025 May 15;27(4):1130-1131. doi: 10.1093/neuonc/noaf023.

DOI:10.1093/neuonc/noaf023
PMID:40249129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12083217/
Abstract
摘要

相似文献

1
Reply to "The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters".对《是时候建立一个整合多尺度分级系统用于异柠檬酸脱氢酶（IDH）突变且1p/19q共缺失的少突胶质细胞瘤，融合影像学和组织分子参数》一文的回复
Neuro Oncol. 2025 May 15;27(4):1130-1131. doi: 10.1093/neuonc/noaf023.
2
The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters.为少突胶质细胞瘤（异柠檬酸脱氢酶（IDH）突变型和1p/19q共缺失）整合多尺度分级系统并结合影像学和组织分子参数的时机已经成熟。
Neuro Oncol. 2025 May 15;27(4):1128-1129. doi: 10.1093/neuonc/noaf022.
3
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.对中枢神经系统WHO 3级异柠檬酸脱氢酶（IDH）突变型和1p/19q共缺失型少突胶质细胞瘤预后因素的重新评估：来自法国POLA队列的经验教训。
Neuro Oncol. 2025 Mar 7;27(3):755-766. doi: 10.1093/neuonc/noae221.
4
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with -Mutant Glioma.将编辑后的磁共振波谱分析纳入临床实践可能会改善携带突变的胶质瘤患者的护理。
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):113-120. doi: 10.3174/ajnr.A8413.
5
IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.异柠檬酸脱氢酶（IDH）突变型和1p/19q共缺失的少突胶质细胞瘤：利用扩散加权磁共振成像、磁敏感加权成像和灌注加权磁共振成像进行肿瘤分级分层
Neuroradiology. 2017 Jun;59(6):555-562. doi: 10.1007/s00234-017-1839-6. Epub 2017 May 4.
6
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.遗传和表观遗传不稳定性是 IDH 突变型星形细胞瘤进展和侵袭性行为的潜在驱动因素。
Acta Neuropathol. 2024 Jul 16;148(1):5. doi: 10.1007/s00401-024-02761-7.
7
Static and dynamic F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.采用静态和动态 F-FET PET 对 IDH 和 1p/19q 状态定义的胶质瘤进行特征分析。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):443-451. doi: 10.1007/s00259-017-3846-6. Epub 2017 Oct 17.
8
Evaluating the efficacy of Hip1R, Vimentin, and H3K27me3 as surrogate markers for 1p/19q co-deletion in oligodendrogliomas.评估Hip1R、波形蛋白和H3K27me3作为少突胶质细胞瘤中1p/19q共缺失替代标志物的疗效。
Neurooncol Adv. 2025 Mar 25;7(1):vdaf060. doi: 10.1093/noajnl/vdaf060. eCollection 2025 Jan-Dec.
9
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.CDKN2A/B半合子缺失在异柠檬酸脱氢酶（IDH）突变型胶质瘤中的预后影响
Neuro Oncol. 2025 Mar 7;27(3):743-754. doi: 10.1093/neuonc/noae238.
10
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.

本文引用的文献

1
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.对中枢神经系统WHO 3级异柠檬酸脱氢酶（IDH）突变型和1p/19q共缺失型少突胶质细胞瘤预后因素的重新评估：来自法国POLA队列的经验教训。
Neuro Oncol. 2025 Mar 7;27(3):755-766. doi: 10.1093/neuonc/noae221.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类：概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.将影像学表现作为成人 IDH 突变型和 1p/19q 联合缺失型少突胶质细胞瘤恶性程度和侵袭性分级的预测指标。
Neuro Oncol. 2020 Jul 7;22(7):993-1005. doi: 10.1093/neuonc/noaa022.
4
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.WHO二级胶质瘤影像学对比增强的预后意义
Neuro Oncol. 2009 Apr;11(2):176-82. doi: 10.1215/15228517-2008-066. Epub 2008 Aug 12.
5
Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.少突胶质细胞瘤。第二部分：基于形态学和影像学标准的新分级系统。
J Neurooncol. 1997 Aug;34(1):61-78. doi: 10.1023/a:1005759220434.
6
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.未经治疗的颅内胶质肿瘤中基于影像学的立体定向系列活检
J Neurosurg. 1987 Jun;66(6):865-74. doi: 10.3171/jns.1987.66.6.0865.